FDA approves new trial design for ALS therapy NurOwn
NeurologyLive - 10-Apr-2024Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts
Join the club for FREE to access the whole archive and other member benefits.
News source for breaking drug approvals, pipeline trials and emerging trends in neurology.
Neurology Live is your trusted news source for breaking drug approvals, pipeline trials and emerging trends in neurology.
Visit website: https://www.neurologylive.com/
Details last updated 06-Feb-2020
Specialized protocol aims to address early-stage ALS and advance regulatory approval efforts
50% improvement in complications of therapy, 19.2% in motor examinations and more